ArticleThe International journal of eating disorders2025
Feasibility and Acceptability of Brief Behavioral Treatment for Insomnia After Eating Disorder Treatment: The TIRED Study.
Article in The International journal of eating disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Recent Advances in Sleep and Circadian Characteristics in Eating Disorders: A Systematic Review of the Last Five Years (2020-2025).Nature and science of sleep · 2026Review
- Feasibility and Acceptability of Brief Behavioral Treatment for Insomnia After Eating Disorder Treatment: The TIRED Study.The International journal of eating disorders · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveThe purpose of this pilot trial was to evaluate the novel use of Brief Behavioral Treatment for Insomnia (BBTI) for people with residual insomnia disorder following eating disorder (ED) treatment.
methodsParticipants (N = 6) completed a multiple-baseline design study of BBTI. The primary outcome was insomnia severity, measured by the Insomnia Severity Index. Secondary outcomes included sleep efficiency and daytime fatigue. Exploratory outcomes were ED-related impairment and symptoms, anxiety symptoms, and depression symptoms.
resultsBBTI reduced insomnia symptom severity from baseline to end of treatment. BBTI also resulted in improvements in sleep efficiency and reductions in daytime fatigue. ED-related and other psychopathology outcomes largely did not change. DISCUSSION: BBTI showed preliminary evidence of efficacy, acceptability, and feasibility among people with residual insomnia following ED treatment. Future studies should use randomized controlled designs to better elicit the effects of BBTI on ED-related outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.